Ovarian Cancer Trial, Recruiting (NCT07197255)

Ovarian Cancer Trial, Recruiting NCT07197255 Sponsor: Mỹ Đức Hospital Condition: Ovarian Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07197255 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Ovarian Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are a woman between 18 and 38 years old
Your body mass index (BMI) is 32 or below (a measure of body weight relative to height)
You have been diagnosed with polycystic ovary syndrome (PCOS) based on having at least 2 of these 3 features: irregular or absent ovulation, signs of higher-than-normal male hormones in your body or blood tests, or a specific appearance of your ovaries on an ultrasound scan
You have been recommended for a specific fertility treatment called CAPA-IVM (a method of maturing eggs outside the body)
Your blood test shows a hormone called AMH is at a level of 4 ng/mL or higher (a marker related to egg supply)
An ultrasound scan shows you have 24 or more small follicles (fluid-filled sacs that contain eggs) across both ovaries
You are willing and able to sign a consent form to take part in the study

Who may not be able to join:

Your partner's sperm was collected through a surgical procedure rather than naturally
You have previously had an IVF cycle where immature eggs were collected (confirm with trial site, as this criterion appears incomplete)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 30 June 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07197255

Sponsor: Mỹ Đức Hospital

Phase: Not Applicable

Status: Recruiting

Condition: Ovarian Cancer

More information: https://clinicaltrials.gov/study/NCT07197255

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are a woman between 18 and 38 years old
Your body mass index (BMI) is 32 or below (a measure of body weight relative to height)
You have been diagnosed with polycystic ovary syndrome (PCOS) based on having at least 2 of these 3 features: irregular or absent ovulation, signs of higher-than-normal male hormones in your body or blood tests, or a specific appearance of your ovaries on an ultrasound scan
You have been recommended for a specific fertility treatment called CAPA-IVM (a method of maturing eggs outside the body)
Your blood test shows a hormone called AMH is at a level of 4 ng/mL or higher (a marker related to egg supply)
An ultrasound scan shows you have 24 or more small follicles (fluid-filled sacs that contain eggs) across both ovaries
You are willing and able to sign a consent form to take part in the study

Who may not be able to join:

Your partner's sperm was collected through a surgical procedure rather than naturally
You have previously had an IVF cycle where immature eggs were collected (confirm with trial site, as this criterion appears incomplete)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 30 June 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Mỹ Đức Hospital

Registry

ClinicalTrials.gov

Start date

16 October 2025

Est. completion

30 January 2026

Where this trial is recruiting

🇻🇳 Vietnam

Primary endpoints

Correlation of cumulus cell transcriptomic profiles with embryological outcomes

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov